Medical device company Tandem Diabetes Care has obtained approval from the US Food and Drug Administration for its t:flex Insulin Pump.


According to the company, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the US, at 480 units.

Tandem Diabetes Care president and CEO Kim Blickenstaff said: "In recognizing that one size does not fit all, the t:flex Pump was developed using Tandem’s proprietary technology platform to bring t:slim’s benefits to people with greater insulin needs.

"This first expansion of our product portfolio reflects our ongoing commitment to deliver user-friendly products that address unmet needs in the diabetes community."

The t:flex Pump has been developed for people who require more than 100 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes.

Without the frequent reservoir changes required by 200 and 300-unit capacity pumps, the device offers people with better pump therapy. It features slim design, advanced Micro-Delivery technology, and simple-to-use touch-screen interface.

The company plans to launch the product in the US, in the second quarter of 2015.

Image: Tandem has designed t:flex Pump for people with type 1 diabetes and type 2 diabetes. Photo: courtesy of David Castillo Dominici/